Description of High Density Lipoprotein (HDL) Levels and the Risk of Atherosclerosis in Patient Aged>50 Years

Authors

Sofiatul Milah , Tuti Suparyati , Bekti Mastiadji

DOI:

10.29303/jbt.v26i4.12805

Published:

2026-10-23

Downloads

Abstract

Atherosclerosis is a chronic progressive disease that remains the leading cause of death and disability worldwide, with a sharply increased risk in individuals over 50 years of age. High-density lipoprotein (HDL) is known as "good cholesterol" that plays a role in protecting blood vessels through reverse cholesterol transport, as well as antioxidant, anti-inflammatory, and antithrombotic properties. However, the association between HDL levels and atherosclerosis risk in the older age group still requires further understanding. To describe the profile of high-density lipoprotein (HDL) levels and atherosclerosis risk in patients aged >50 years at RS QIM Batang. This descriptive study used secondary data from medical records of 25 patients aged >50 years who underwent lipid profile examination. Samples were selected using purposive sampling technique. Analyzed data included total cholesterol, triglyceride, HDL, and LDL levels, as well as the LDL/HDL ratio, presented in the form of frequency distribution tables, percentag kues, and descriptive statistical values. HDL levels of the subjects ranged from 7–57 mg/dL, with a mean of 37.2 mg/dL. A total of 56% of patients had normal HDL levels, 36% had low levels, and only 8% had high levels. The mean LDL level was 115.0 mg/dL, with 80% of patients within the normal limit, while the mean LDL/HDL ratio reached 3.2. Total cholesterol levels ranged from 95–257 mg/dL (mean 191.9 mg/dL) and triglycerides from 63–630 mg/dL (mean 222.6 mg/dL). Most patients aged >50 years had normal HDL levels, yet more than one third showed decreased HDL levels, which may increase atherosclerosis risk. The mean LDL/HDL ratio also indicates a tendency toward a relatively high risk in this age group.

Keywords:

Atherosclerosis Age >50 Years High-Density Lipoprotein Lipid Profile

References

Abdellatif, M., Rainer, P. P., & Kroemer, G. (2023). Hallmarks of cardiovascular ageing. Nature Reviews Cardiology, 20, 754–777. https://doi.org/10.1038/s41569-023-00881-3

Andrade, C. (2020). The Inconvenient Truth About Convenience and Purposive samples. Journal of Psychological Medicine, 43(1), 86–88. https://doi.org/10.1177/0253717620977000

Boren, J., Chapman, J. M., Krauss, R. M., Packard, C. J., & Bentzon, J. F. (2020). Low-desnity Lipoproteins cause Atherosclerotic Cardiovaskular Disease: Pathophysiological, Genetic, and Therapeutic Insights. European Heart Journal, 41(24), 2313–2330. https://doi.org/10.1093/eurheartj/ehz962

Boren, J., & Williams, K. (2016). The central Role of Arterial Retention of Cholesterol-rich Apoliporpotein-B-containing Lipoproteins in the Pathogenesis of Atherosclerosis. Current Opinion in Lipidology, 27(5), 473–483. https://pubmed.ncbi.nlm.nih.gov/?term=Boren+Williams+arterial+retention+apoliporotein+B+atherosclerosis

Campbell, S., Greenwood, M., Prior, S., Shearer, T., & Walkem, K. (2020). Purposive Sampling: Complex or Simple? Journal of Research in Nursing, 25(8), 652–661. https://doi.org/10.1177/1744987120927206

Cao, J., Donato, L., El-Khoury, J. M., Goldberg, A., Meeusen, J. W., & Remaley, A. T. (2024). ADLM Guidance Document on the Measurement and Reporting of Lipids and Lipoproteins. The Journal of Applied Laboratory Medicine, 9(5), 1040–1056. https://doi.org/10.1093/jalm/jfae057

Castelli, W., Anderson, K., Wilson, P., & Levy, D. (1992). Lipids and Risk of Coronary Heart Disease. Annals of Epidemiology, 2(1–2), 23–28. https://doi.org/10.1016/1047-2797(92)90033-m.

Donato, A. J., Machin, D. R., & Lesniewski, L. A. (2018). Mechanisms of Dysfunction in the Aging Vasculature and Role in Age-Related Disease. Circulation Research, 123(7), 825–848. https://doi.org/10.1161/CIRCRESAHA.118.312563

El Khoudary, S. R. (2017). HDL and the Menopause. Current Opinion in Lipidology, 28(4), 328–336. https://doi.org/10.1097/MOL.0000000000000432

Fadhilah, F. R., Sari, A. B., & Aprilianti, A. (2019). The Effect of Test Tube Sterilization from Serum Lipemic Against Levels of Triglyceride GPO-PAP Method. Indonesian Journal of Medical Laboratory Science and Technology, 1(1), 38–43. https://doi.org/10.33086/ijmlst.v.1i1.878

Ference, B. A., Kastelein, J. J., Ray, K. K., Ginsberg, H. N., & Chapman, M. J. (2019). Association of Triglyceride-lowering LPL Variants and LDL-C-Lowering LDLR Variants with Risk of Coronary Heart Disease. JAMA, 321(4), 364–373. https://doi.org/10.1001/jama.2018.20045

Ginsberg, H. N., Packard, C. J., Champman, M. J., Boren, J., Aguilar-Salinas, C. A., & Averna, M. (2021). Triglyceride-rich Lipoproteins and their Remnants: Metabolic Insights, Role in Atherosclerotic Cardiovascular Disease, and Emerging Therpeutic Strategies-a consensus Statement from the European Atherosclerosis Society. European Heart Journal, 42(47), 4791–4806. https://doi.org/10.1093/eurheartj/ehab551

Hong, B. V, Zheng, J. Y., & Zivkovic, A. M. (2023). HDL Function across the Lifespan: From Childhood, to Pregnancy, to Old Age. International Journal of Molecular Sciences, 24(20), 15305. https://doi.org/10.3390/ijms242015305

Kementerian Kesehatan Republik Indonesia. (2022). Penyakit Jantung Penyebab Utama Kematian, Kemenkes Perkuat Layanan Primer. https://kemenkes.go.id/id/penyakit-jantung-penyebab-utama-kematian-kemenkes-perkuat-layanan-primer

Kementerian Kesehatan Republik Indonesia. (2023). Survei Kesehatan Indonesia (SKI) 2023: Tabel 7.29 Prevalensi Penyakit Jantung berdasarkan Diagnosis Dokter pada Penduduk Semua Umur menurut Karakteristik. https://kemenkes.go.id/app_asset/file_content_download/17169067256655eae5553985.98376730.pdf

Langlois, M. R., Nordestgaard, B. G., Langsted, A., Wiklund, O., & Laitinen, P. (2020). Quantifiying Atherogenic Lipoproteins for Lipid-lowering Strategies: Consensus-based Recommendations from EAS and EFLM. Atherosclerosis, 294, 46–61. https://doi.org/10.1016/j.atherosclerosis.2019.12.005

Libby, P., Buring, J. E., & Lewis, E. F. (2019). Atherosclerosis. Nature Reviews Disease Primers, 5(56). https://doi.org/10.1038/s41572-019-0106-z

Nofer, J. R., Kehrel, B., Fobker, M., & Levkau, B. (2002). HDL and Arteriosclerosis: Beyond Reverse Cholesterol Transport. Atherosclerosis, 161(1), 1–16. https://doi.org/10.1016/S0021-9150(01)00651-7

Ouimet, M., Barret, T., & Fisher, E. (2019). HDL and Reverse Cholesterol Transport. Circulation Research, 124(10), 1505–1518. https://doi.org/10.1161/CIRCRESAHA.119.312617

Pownall, H. J., Rosales, C., & Gotto Jr, A. M. (2021). High-density Lipoproteins, Reverse Cholesterol Transport and Atherogenesis. Nature Reviews Cardiology, 18, 712–723. https://doi.org/10.1038/s41569-021-00538-z

Pratama, D., Rahmaditya, F. S., Utama, A. J., Suhartono, R., & Muradi, A. (2023). Risk Factors of Asymptomatic Carotid Artery Disease in Geriatric Evaluated Using Carotid Intima-Media Thickness (IMT) Measurement, the First Indonesian Population Study. Journal of Analogy, 32(02), 095–099. https://doi.org/10.1055/s-0042-1750040

Rosenson, R. S., Brewer, B., Davidson, S., Fayad, Z. A., Fuster, V., Goldstein, J., & Hellerstein, M. (2012). Cholesterol Efflux and Atheroprotection: Advancing the Concept of Reverse Cholesterol Transport. Circulation, 125(15), 1905–1919. https://doi.org/10.1161/CIRCULATIONAHA.111.066589

Shifa, J.-B., Galicia-Galicia, U., Larrea-Sebal, A., Olaetxea, J. R., & Alloza, I. (2022). Pathophysiology of Atherosclerosis. International Journal of Molecular Sciences, 23(6), 3346. https://doi.org/10.3390/ijms23063346

Syahputri, C. Y., & Ansyari, D. (2026). Hubungan Rasio Low-density Lipoprotein dengan Derajat Keparahan Lesi Aterosklerosis pada Pasien Penyakit Jantung Koroner di Rumah Sakit Umum Haji Medan. GALENICAL: Jurnal Kedokteran dan Kesehatan Mahasiswa Malikussaleh, 5(4). https://doi.org/10.29103/jkkmm.v5i4.29119

Tsompanidi, E. M., Brinkmeier, M. S., Fotiadou, E. H., & Giakoumi, S. M. (2010). HDL Biogenesis and Functions: Role of HDL Quality and Quanty in Atherosclerosis. Atherosclerosis, 208(1), 3–9. https://doi.org/10.1016/j.atherosclerosis.2009.05.034

Virani, S. S., Morris, P. B., Agarwala, A., Ballanyne, C. M., & Birther, K. K. (2021). ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglycerid. Journal of the American Collage of Cardiology, 78(9), 960–993. https://doi.org/10.1016/j.jacc.2021.06.011

World Health Organization. (2010). WHO Guidelines on Drawing Blood: Best Practices in Phlebotomy. Geneva: WHO. https://www.who.int/publications/i/item/9789241599221

World Health Organization. (2023). Best Practices for Collection, Processing, and Storage of Serum Specimens. Geneva: WHO. https://iris.who.int/bitstream/handle/10665/375814/9789240084476-eng.pdf

Author Biographies

Sofiatul Milah, Akademi Analis Kesehatan Pekalongan

Author Origin : Indonesia

Tuti Suparyati, Akademi Analis Kesehatan Pekalongan

Author Origin : Indonesia

Bekti Mastiadji, Akademi Analis Kesehatan Pekalongan

Author Origin : Indonesia

Downloads

Download data is not yet available.

How to Cite

Milah, S., Suparyati, T., & Mastiadji, B. (2026). Description of High Density Lipoprotein (HDL) Levels and the Risk of Atherosclerosis in Patient Aged>50 Years . Jurnal Biologi Tropis, 26(4), 879–885. https://doi.org/10.29303/jbt.v26i4.12805